BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19433712)

  • 21. Nasolacrimal duct intubation in the treatment of congenital nasolacrimal duct obstruction in older children.
    Okumuş S; Öner V; Durucu C; Coşkun E; Aksoy Ü; Durucu E; Şahin L; Erbağcı I
    Eye (Lond); 2016 Jan; 30(1):85-8. PubMed ID: 26449195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasolacrimal duct obstruction in children: outcome of intubation.
    Lim CS; Martin F; Beckenham T; Cumming RG
    J AAPOS; 2004 Oct; 8(5):466-72. PubMed ID: 15492741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of treatment approaches for bilateral congenital nasolacrimal duct obstruction.
    Lee KA; Chandler DL; Repka MX; Melia M; Beck RW; Summers CG; Frick KD; Foster NC; Kraker RT; Atkinson S;
    Am J Ophthalmol; 2013 Nov; 156(5):1045-50. PubMed ID: 23954210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the length of intubation affect the success of treatment for congenital nasolacrimal duct obstruction?
    Komínek P; Cervenka S; Matousek P
    Ophthalmic Plast Reconstr Surg; 2010; 26(2):103-5. PubMed ID: 20305509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Office probing for treatment of nasolacrimal duct obstruction in infants.
    Miller AM; Chandler DL; Repka MX; Hoover DL; Lee KA; Melia M; Rychwalski PJ; Silbert DI; ; Beck RW; Crouch ER; Donahue S; Holmes JM; Quinn GE; Sala NA; Schloff S; Wallace DK; Foster NC; Frick KD; Golden RP; Lambert SR; Tien DR; Weakley DR
    J AAPOS; 2014 Feb; 18(1):26-30. PubMed ID: 24568978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Endoscopically Assisted Primary Probing and Bicanalicular Silicone Intubation for Congenital Nasolacrimal Duct Obstruction in Children Aged 4 to 7 Years.
    Arici C; Mergen B; Ozan T; Batu Oto B
    J Pediatr Ophthalmol Strabismus; 2023; 60(2):101-107. PubMed ID: 35446188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silicone intubation for the treatment of epiphora in adults with presumed functional nasolacrimal duct obstruction.
    Moscato EE; Dolmetsch AM; Silkiss RZ; Seiff SR
    Ophthalmic Plast Reconstr Surg; 2012; 28(1):35-9. PubMed ID: 22262288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High incidence and recurrence of tympanostomy tube procedures in children who underwent nasolacrimal duct probe and intubation for congenital nasolacrimal duct obstruction.
    Vicinanzo MG; Cooper KM; Gerber AL; Long J; McGwin G
    J AAPOS; 2023 Oct; 27(5):286.e1-286.e4. PubMed ID: 37734706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors Associated With Nasolacrimal Duct Probing Failure Among Children in the Intelligent Research in Sight Registry.
    Oke I; Elze T; Miller JW; Lorch AC; Hunter DG; Elliott AT;
    JAMA Ophthalmol; 2023 Apr; 141(4):342-348. PubMed ID: 36862386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Balloon-catheter dilatation (dacrioplasty) for congenital nasolacrimal duct obstruction treatment].
    Carvalho RM; Seronni LB; Avila M
    Arq Bras Oftalmol; 2009; 72(5):669-72. PubMed ID: 20027407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Success rates of primary probing for congenital nasolacrimal obstruction in children.
    Arora S; Koushan K; Harvey JT
    J AAPOS; 2012 Apr; 16(2):173-6. PubMed ID: 22525175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simple technique for silicone intubation in congenital nasolacrimal duct obstruction.
    Lekskul A; Khamapirad B; Nimvorapun T
    J Med Assoc Thai; 2004 Sep; 87(9):1082-6. PubMed ID: 15516010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double silicone intubation as treatment for persistent congenital nasolacrimal duct obstruction.
    Mauffray RO; Hassan AS; Elner VM
    Ophthalmic Plast Reconstr Surg; 2004 Jan; 20(1):44-9. PubMed ID: 14752310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dilation probing as primary treatment for congenital nasolacrimal duct obstruction.
    Clark RA
    J AAPOS; 2002 Dec; 6(6):364-7. PubMed ID: 12506277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of short-duration silicone intubation in congenital nasolacrimal duct obstruction.
    Peterson NJ; Weaver RG; Yeatts RP
    Ophthalmic Plast Reconstr Surg; 2008; 24(3):167-71. PubMed ID: 18520828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Factors affected therapeutic results in treatment of children congenital nasolacrimal duct obstruction by Ritleng lacrimal intubation].
    Yu G; Hu M; Wu Q; Cao WH; Fan YW; Lin Q; Liu W
    Zhonghua Yan Ke Za Zhi; 2012 May; 48(5):423-7. PubMed ID: 22932332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital lacrimal system obstruction: treatment with balloon dilation.
    Cho YS; Song HY; Ko GY; Yoon CH; Ahn HS; Yoon HK; Sung KB
    J Vasc Interv Radiol; 2000; 11(10):1319-24. PubMed ID: 11099243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Balloon catheter dilation for treatment of older children with nasolacrimal duct obstruction.
    Lueder GT
    Arch Ophthalmol; 2002 Dec; 120(12):1685-8. PubMed ID: 12470143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silastic intubation in congenital nasolacrimal duct obstruction: a study of 129 eyes.
    al-Hussain H; Nasr AM
    Ophthalmic Plast Reconstr Surg; 1993; 9(1):32-7. PubMed ID: 8443112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nasal endoscopic features and outcomes of nasal endoscopy guided bicanalicular intubation for complex persistent congenital nasolacrimal duct obstructions.
    Singh M; Sharma M; Kaur M; Grewal AM; Yadav D; Handa S; Yangzes S; Zadeng Z; Gupta P
    Indian J Ophthalmol; 2019 Jul; 67(7):1137-1142. PubMed ID: 31238429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.